NEW YORK — Beckman Coulter Life Sciences and IncellDx said today that they have partnered to promote in Europe four newly developed cancer assays that incorporate technology from each company.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.